Report Scope: The current report offers a detailed picture of the market for plasma fractionation.
This report highlights the current and future market potential for plasma fractionation and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and trends in the market. The report also covers market projections through 2025, as well as key market players.
This report details market shares for plasma fractionation based on product, application, end user and geography.Based on product, the market is segmented into immunoglobulins, albumins, coagulation factor concentrates and other segments.
Based on application, the market is segmented into neurology, immunology, hematology and others. Based on end user, the market segmented into hospitals and clinics, research laboratories and others.
Based on geography, the market has been segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Detailed analyses of major countries (the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India) are covered in regional segments. For market estimates, data has been provided for 2020 as the base year, with forecasts for 2020 through 2025. Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Includes: - 27 data tables and 25 additional tables - Comprehensive overview of the global markets for plasma fractionation and its sub-segments - Analyses of the global market trends, with data from 2019, estimates for 2020, and projections of compound annual growth rates (CAGRs) through 2025 - Estimation of the actual market size and revenue forecasts for plasma fractionation, and market share analysis on the basis of product type, application, end user and geographical region - Country specific data and analysis of the U.S., Canada, France, Germany, U.K., Italy, Spain, Australia, India, Japan, China and other emerging economies from the Latin America and MEA regions - Insights into the market potential for plasma fractionation, opportunities and restraints, regulatory updates, and technological trends and issues impacting the industry - Impact analysis of COVID-19 pandemic on the growth of plasma fractionation industry vs. its impact on social and geopolitical spheres - Porter’s Five Forces analysis of the market for plasma fractionation and global company ranking within the market - Profile descriptions of the market leading participants, including ADMA Biologics Inc., Baxter International Inc., China Biologic Products Holdings Inc., CSL Ltd., and Grifols, S.A.
Summary: The global market for plasma fractionation was valued at REDACTED in 2019.The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED to reach REDACTED by 2025.
Growth of the global market is attributed to the increasing use of immunoglobulins in various therapeutic areas.
This increase is a result of the rising prevalence of Alpha-1 antitrypsin deficiency and respiratory diseases and the growing global geriatric population.
The global market for plasma fractionation is segmented in this report by product, application, end user and region.
Reasons for Doing This Study Plasma, the largest component of blood, accounts for 55% of total blood composition.Plasma consists of various components such as water, electrolytes, albumin and immunoglobulins, among others.
Each component of blood plasma performs a different function in the body and plays a vital role in ensuring the effective performance of other body organs.Additionally, plasma serves as a carrier for nutrients and hormones as well as the proteins that transport these components throughout the body.
Blood plasma is a major source of immunoglobulins and is used in the treatment of patients suffering from immunoglobulin deficiency.Exploring the potential of blood plasma in the large-scale treatment of immuno-compromised patients has become essential with the emerging incidences of primary as well as secondary immunodeficiencies.
An increase in the cases of bleeding disorders such as hemophilia A, hemophilia B and von Willebrand disease has resulted in a better understanding of blood plasma and its potential in the treatment of these diseases. Hence, the study of blood plasma fractionation products helps improve the understanding of blood plasma and the potential of using blood plasma therapies in chronic disease management.
Our reports have been used by over 10K customers, including:
Plasma Fractionation Market Report Overview Plasma Fractionation market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Plasma Fractionation market types and applications. It is a focused study on Plasma Fractionation market space including...
The global catalyst handling services market size is projected to reach USD 620 million by 2025 from USD 510 million in 2020, at a CAGR of 4.0% during the forecast period. The demand for catalyst handling services in emerging economies, such as APAC, MEA, and South America, is increasing owing to the growth in industrial activities. Increasing...
2021 Protein Fractionation Market - Size, Share, COVID Impact Analysis and Forecast to 2027 2021 Protein Fractionation Market - Size, Share, COVID Impact Analysis and Forecast to 2027 – is comprehensive research with in-depth data and contemporary analysis of Protein Fractionation Market at a global, regional and key...
230 pages •
By Transparency Market Research
• Dec 2020
Mineral Oil & Mineral Spirit Market – Scope of the Report
The analyst’s recent report on the global mineral oil & mineral spirit market provides readers with an assessment of the landscape of the market with the help of a comprehensive outlook.This study on the global mineral oil & mineral spirit market analyzes the market...
Refining Industry Outlook in Africa to 2024 - Capacity and Capital Expenditure Outlook with Details of All Operating and Planned Refineries
The total refining capacity of Africa in 2019 was 3,712 mbd. The refining capacity in Africa increased from 3,498 thousand barrels of oil per day...
The hydrogen generation market is projected to reach USD 201 billion by 2025 from an estimated USD 130 billion in 2020, at a CAGR of 9.2% during the forecast period. Rising obligations to reduce greenhouse gas emissions from traditional methods has driven the hydrogen generation market growth. Furthermore, increased demand for long-term storage...
Refining Industry Outlook in Middle East to 2024 - Capacity and Capital Expenditure Outlook with Details of All Operating and Planned Refineries
Refining Industry Outlook in Middle East to 2024 - Capacity and Capital Expenditure Outlook with Details of All Operating and Planned Refineries...
Refining Industry Outlook in Asia and Oceania to 2024 - Capacity and Capital Expenditure Outlook with Details of All Operating and Planned Refineries
Refining Industry Outlook in Asia and Oceania to 2024 - Capacity and Capital Expenditure Outlook with Details of All Operating and Planned...
Growing use of immunoglobulins in various therapeutic areas, increase in plasma collection (and the number of plasma collection centers), and the growing prevalence of respiratory diseases and alpha-1-antitrypsin deficiency (AATD) is expected to drive the overall growth of the plasma fractionation market. The global plasma fractionation...
Global Crude Oil Refinery Maintenance Review, 2020 - Asia and North America Witness the Highest Maintenance in the Year Summary In 2020, Asia had the highest refining capacity under maintenance (both planned and unplanned) globally with 11,524 mbd.In terms of highest capacity under planned maintenance,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.